Cleared Traditional

K023701 - ANGIONEW-IV

K023701 is an FDA 510(k) clearance for ANGIONEW-IV, manufactured by Living Data Technologies Corporation. The device is a Class 2 Cardiovascular device with product code DRN cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K023701 · Living Data Technologies Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2003
Decision
87d
Days
Class 2
Risk

K023701 is an FDA 510(k) clearance for the ANGIONEW-IV. Classified as Device, Counter-pulsating, External (product code DRN), Class II - Special Controls.

Submitted by Living Data Technologies Corporation (Great Neck, US). The FDA issued a Cleared decision on January 30, 2003 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5225 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Living Data Technologies Corporation devices

FDA 510(k) Submission Details - K023701

510(k) Number K023701 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2002
Decision Date January 30, 2003
Days to Decision 87 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 125d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRN Device Classification - Class 2, Special Controls

Product Code DRN Device, Counter-pulsating, External
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRN Device, Counter-pulsating, External

All 8
Devices cleared under the same product code (DRN) and FDA review panel - the closest regulatory comparables to K023701.
External Counterpulsation System
K190683 · Vamed Medical Instrument Co., Ltd. · Sep 2019
Pure Flow External Counter-Pulsation Device
K173483 · Xtreem Pulse, LLC · May 2018
EXTERNAL COUNTERPULSATION DEVICE WITH SP02 MORNITORING
K130439 · Chongqing Psk Sci-Tech Development Co., Ltd. · Dec 2013
NICORE MODEL ESP -1
K980937 · Nicore Equipment & Leasing, Inc. · Sep 2000
THE CIRCULATOR BOOT
K971026 · Circulator Boot Corp. · Aug 1997